T-Vobit 2 Tablet SR
Product Overview:
T-Vobit 2 Tablet SR is a combination medicine used to treat type 2 diabetes in adults. It helps control blood sugar levels by slowing down sugar absorption and increasing insulin release, making it easier to manage diabetes and reduce the risk of complications.
How to Use:
Take T-Vobit 2 Tablet SR with or just before meals, at the same time each day. Follow your doctor’s instructions on the dose. Keep taking this medicine even if you feel well, as stopping it could cause your blood sugar to rise, increasing the risk of serious problems like kidney damage, nerve issues, or vision loss.
Benefits:
-
Controls blood sugar after meals
-
Helps remove excess sugar from the body
-
Reduces risk of diabetes-related complications
-
Supports heart health in diabetic patients with heart conditions
Common Side Effects:
-
Nausea and vomiting
-
Stomach pain or diarrhea
-
Loss of appetite
-
Low blood sugar symptoms like sweating, dizziness, headache, or shaking
Always carry a fast-acting sugar source, like fruit juice, in case your blood sugar drops too low. Avoid alcohol as it can increase this risk.
Who Should Not Take This:
-
People with type 1 diabetes
-
Those with diabetic ketoacidosis
-
Patients with severe kidney or liver problems
-
Pregnant or breastfeeding women should consult their doctor before use
Safety Advice:
-
Alcohol: Avoid while taking this medicine.
-
Pregnancy & Breastfeeding: Consult your doctor.
-
Driving: Be cautious if you experience dizziness or low blood sugar.
-
Kidney & Liver: Use with care; your doctor may need to monitor your health regularly.
Missed Dose:
If you miss a dose, take it as soon as you remember unless it’s close to the next dose. Do not double your dose.
How It Works:
T-Vobit 2 Tablet SR combines three medicines:
-
Glimepiride: Helps the pancreas release more insulin.
-
Metformin: Reduces sugar production in the liver and improves insulin use.
-
Voglibose: Slows down the breakdown of sugars in the intestines to prevent blood sugar spikes after meals.
Leave a Reply